Lung cancer (LC) is a leading cause of global cancer-related deaths, highlighting the development of innovative methods for biomarker detection improving the early diagnostics. microRNAs (miRs) alterations are known to be involved in the initiation and progression of human cancers and can act as biomarkers for diagnostics and treatment.

中文翻译：

---

使用分子信标评估人肺腺癌细胞系中的 miR-155 沉默

肺癌（LC）是全球癌症相关死亡的主要原因，凸显了生物标志物检测创新方法的发展，改善了早期诊断。已知 microRNA (miR) 的改变与人类癌症的发生和进展有关，并且可以作为诊断和治疗的生物标志物。